West Pharmaceutical Services, Inc (WST) EPS growth this year is -17.76%: Get Prepared for Trading Lift Off

West Pharmaceutical Services, Inc (NYSE: WST) open the trading on Wednesday, with great promise as it jumped 4.98% to $344.00, before settling in for the price of $327.68 at the close. Taking a more long-term approach, WST posted a 52-week range of $265.00-$413.70.

It was noted that the giant of the Healthcare sector posted annual sales growth of 11.96% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 23.49%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -17.76%. This publicly-traded company’s shares outstanding now amounts to $73.50 million, simultaneously with a float of $72.00 million. The organization now has a market capitalization sitting at $24.91 billion. At the time of writing, stock’s 50-day Moving Average stood at $304.87, while the 200-day Moving Average is $336.00.

West Pharmaceutical Services, Inc (WST) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Instruments & Supplies industry. West Pharmaceutical Services, Inc’s current insider ownership accounts for 0.59%, in contrast to 96.14% institutional ownership. According to the most recent insider trade that took place on Oct 29 ’24, this organization’s VP & Treasurer sold 703 shares at the rate of 310.40, making the entire transaction reach 218,211 in total value, affecting insider ownership by 1,253. Preceding that transaction, on Aug 19 ’24, Company’s VP & Treasurer sold 1,029 for 300.00, making the whole transaction’s value amount to 308,700. This particular insider is now the holder of 1,478 in total.

West Pharmaceutical Services, Inc (WST) Earnings and Revenue Records

West Pharmaceutical Services, Inc’s EPS decrease for this current 12-month fiscal period is -17.76% and is forecasted to reach 7.55 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 2.50% through the next 5 years, which can be compared against the 23.49% growth it accomplished over the previous five years trading on the market.

West Pharmaceutical Services, Inc (NYSE: WST) Trading Performance Indicators

Let’s observe the current performance indicators for West Pharmaceutical Services, Inc (WST). It’s Quick Ratio in the last reported quarter now stands at 2.23. The Stock has managed to achieve an average true range (ATR) of 11.27. Alongside those numbers, its PE Ratio stands at $51.03, and its Beta score is 1.01. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 8.66. Similarly, its price to free cash flow for trailing twelve months is now 77.47.

In the same vein, WST’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 6.74, a figure that is expected to reach 1.71 in the next quarter, and analysts are predicting that it will be 7.55 at the market close of one year from today.

Technical Analysis of West Pharmaceutical Services, Inc (WST)

[West Pharmaceutical Services, Inc, WST] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 77.80% While, its Average True Range was 11.71.

Raw Stochastic average of West Pharmaceutical Services, Inc (WST) in the period of the previous 100 days is set at 90.46%, which indicates a major fall in contrast to 91.73% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 44.26% that was lower than 45.05% volatility it exhibited in the past 100-days period.